Literature DB >> 28484008

mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells.

Bogdan Beirowski1,2, Keit Men Wong3, Elisabetta Babetto3,4, Jeffrey Milbrandt5,6.   

Abstract

The myelination of axons in peripheral nerves requires precisely coordinated proliferation and differentiation of Schwann cells (SCs). We found that the activity of the mechanistic target of rapamycin complex 1 (mTORC1), a key signaling hub for the regulation of cellular growth and proliferation, is progressively extinguished as SCs differentiate during nerve development. To study the effects of different levels of sustained mTORC1 hyperactivity in the SC lineage, we disrupted negative regulators of mTORC1, including TSC2 or TSC1, in developing SCs of mutant mice. Surprisingly, the phenotypes ranged from arrested myelination in nerve development to focal hypermyelination in adulthood, depending on the level and timing of mTORC1 hyperactivity. For example, mice lacking TSC2 in developing SCs displayed hyperproliferation of undifferentiated SCs incompatible with normal myelination. However, these defects and myelination could be rescued by pharmacological mTORC1 inhibition. The subsequent reconstitution of SC mTORC1 hyperactivity in adult animals resulted in focal hypermyelination. Together our data suggest a model in which high mTORC1 activity promotes proliferation of immature SCs and antagonizes SC differentiation during nerve development. Down-regulation of mTORC1 activity is required for terminal SC differentiation and subsequent initiation of myelination. In distinction to this developmental role, excessive SC mTORC1 activity stimulates myelin growth, even overgrowth, in adulthood. Thus, our work delineates two distinct functions of mTORC1 in the SC lineage essential for proper nerve development and myelination. Moreover, our studies show that SCs retain their plasticity to myelinate and remodel myelin via mTORC1 throughout life.

Entities:  

Keywords:  axon; mammalian target of rapamycin; myelination; neuropathy; peripheral nerve

Mesh:

Substances:

Year:  2017        PMID: 28484008      PMCID: PMC5448230          DOI: 10.1073/pnas.1620761114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

2.  Arrest of myelination and reduced axon growth when Schwann cells lack mTOR.

Authors:  Diane L Sherman; Michiel Krols; Lai-Man N Wu; Matthew Grove; Klaus-Armin Nave; Yann-Gaël Gangloff; Peter J Brophy
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

3.  The cyclin-dependent kinase inhibitor p27(Kip1) is a positive regulator of Schwann cell differentiation in vitro.

Authors:  Honghui Li; Huiguang Yang; Yonghua Liu; Weipeng Huan; Shuangwei Zhang; Gang Wu; Qiuhui Lu; Qiuhong Wang; Youhua Wang
Journal:  J Mol Neurosci       Date:  2011-04-12       Impact factor: 3.444

4.  Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

Authors:  Jessica L Yecies; Hui H Zhang; Suchithra Menon; Sihao Liu; Derek Yecies; Alex I Lipovsky; Cem Gorgun; David J Kwiatkowski; Gökhan S Hotamisligil; Chih-Hao Lee; Brendan D Manning
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

5.  mTORC1 controls PNS myelination along the mTORC1-RXRγ-SREBP-lipid biosynthesis axis in Schwann cells.

Authors:  Camilla Norrmén; Gianluca Figlia; Frédéric Lebrun-Julien; Jorge A Pereira; Martin Trötzmüller; Harald C Köfeler; Ville Rantanen; Carsten Wessig; Anne-Lieke F van Deijk; August B Smit; Mark H G Verheijen; Markus A Rüegg; Michael N Hall; Ueli Suter
Journal:  Cell Rep       Date:  2014-10-09       Impact factor: 9.423

6.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Nicholas R Rensing; Bo Zhang; David H Gutmann; Michael J Gambello; Michael Wong
Journal:  Hum Mol Genet       Date:  2010-11-09       Impact factor: 6.150

7.  Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.

Authors:  Suchithra Menon; Christian C Dibble; George Talbott; Gerta Hoxhaj; Alexander J Valvezan; Hidenori Takahashi; Lewis C Cantley; Brendan D Manning
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

8.  P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells.

Authors:  M L Feltri; M D'Antonio; S Previtali; M Fasolini; A Messing; L Wrabetz
Journal:  Ann N Y Acad Sci       Date:  1999-09-14       Impact factor: 5.691

9.  Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination.

Authors:  Maria E Sheean; Erik McShane; Cyril Cheret; Jan Walcher; Thomas Müller; Annika Wulf-Goldenberg; Soraya Hoelper; Alistair N Garratt; Markus Krüger; Klaus Rajewsky; Dies Meijer; Walter Birchmeier; Gary R Lewin; Matthias Selbach; Carmen Birchmeier
Journal:  Genes Dev       Date:  2014-02-01       Impact factor: 11.361

10.  mTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation.

Authors:  Bo Yan; Zhongmin Zhang; Dadi Jin; Chen Cai; Chunhong Jia; Wen Liu; Ting Wang; Shengfa Li; Haiyan Zhang; Bin Huang; Pinglin Lai; Hua Wang; Anling Liu; Chun Zeng; Daozhang Cai; Yu Jiang; Xiaochun Bai
Journal:  Nat Commun       Date:  2016-04-04       Impact factor: 14.919

View more
  24 in total

1.  mTORC1 promotes Schwann cell cycling and myelinogenesis.

Authors:  Bogdan Beirowski; Keit Men Wong
Journal:  Cell Cycle       Date:  2017-08-18       Impact factor: 4.534

Review 2.  A Glance at the Molecules That Regulate Oligodendrocyte Myelination.

Authors:  Shunqi Wang; Yingxing Wang; Suqi Zou
Journal:  Curr Issues Mol Biol       Date:  2022-05-15       Impact factor: 2.976

3.  Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex.

Authors:  Bethany K Terry; Raehee Park; Seo-Hee Cho; Peter B Crino; Seonhee Kim
Journal:  Hum Mol Genet       Date:  2022-06-22       Impact factor: 5.121

4.  The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner.

Authors:  Minqing Jiang; Rohit Rao; Jincheng Wang; Jiajia Wang; Lingli Xu; Lai Man Wu; Jonah R Chan; Huimin Wang; Q Richard Lu
Journal:  Glia       Date:  2018-05-03       Impact factor: 7.452

5.  HERC1 Ubiquitin Ligase Is Required for Normal Axonal Myelination in the Peripheral Nervous System.

Authors:  Sara Bachiller; María Angustias Roca-Ceballos; Irene García-Domínguez; Eva María Pérez-Villegas; David Martos-Carmona; Miguel Ángel Pérez-Castro; Luis Miguel Real; José Luis Rosa; Lucía Tabares; José Luis Venero; José Ángel Armengol; Ángel Manuel Carrión; Rocío Ruiz
Journal:  Mol Neurobiol       Date:  2018-03-30       Impact factor: 5.590

6.  Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy.

Authors:  Amber R Hackett; Amy Strickland; Jeffrey Milbrandt
Journal:  Glia       Date:  2019-11-23       Impact factor: 7.452

7.  Comprehensive Analysis of Age-related Changes in Lipid Metabolism and Myelin Sheath Formation in Sciatic Nerves.

Authors:  David Djuanda; Bo He; Xiangxia Liu; Shuqia Xu; Yi Zhang; Yangbin Xu; Zhaowei Zhu
Journal:  J Mol Neurosci       Date:  2021-01-25       Impact factor: 3.444

Review 8.  Myelin Biology.

Authors:  Alessandra Bolino
Journal:  Neurotherapeutics       Date:  2021-07-09       Impact factor: 6.088

9.  A glycolytic shift in Schwann cells supports injured axons.

Authors:  Elisabetta Babetto; Keit Men Wong; Bogdan Beirowski
Journal:  Nat Neurosci       Date:  2020-08-17       Impact factor: 24.884

10.  Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.

Authors:  Akihiro Ishii; Miki Furusho; Rashmi Bansal
Journal:  Glia       Date:  2021-06-22       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.